| Markers of Intestinal Inflammation, Not Bacterial Burden, Correlate With Clinical Outcomes in Clostridium difficile Infection RE El Feghaly, JL Stauber, E Deych, C Gonzalez, PI Tarr, DB Haslam Clinical infectious diseases 56 (12), 1713-1721, 2013 | 208 | 2013 |
| Metagenomic approach for identification of the pathogens associated with diarrhea in stool specimens Y Zhou, KM Wylie, RE El Feghaly, KA Mihindukulasuriya, A Elward, ... Journal of Clinical Microbiology 54 (2), 368-375, 2016 | 90 | 2016 |
| Intestinal inflammatory biomarkers and outcome in pediatric Clostridium difficile infections RE El Feghaly, JL Stauber, PI Tarr, DB Haslam The Journal of pediatrics 163 (6), 1697-1704. e2, 2013 | 79 | 2013 |
| Presence of the blaZ beta-lactamase gene in isolates of Staphylococcus aureus that appear penicillin susceptible by conventional phenotypic methods RE El Feghaly, JE Stamm, SA Fritz, CAD Burnham Diagnostic microbiology and infectious disease 74 (4), 388-393, 2012 | 64 | 2012 |
| MAPK-activated protein kinase 2 contributes to Clostridium difficile-associated inflammation LD Bobo, RE El Feghaly, YS Chen, ER Dubberke, Z Han, AH Baker, J Li, ... Infection and immunity 81 (3), 713-722, 2013 | 61 | 2013 |
| Viral co-infections are common and are associated with higher bacterial burden in children with Clostridium difficile infection RE El Feghaly, JL Stauber, PI Tarr, DB Haslam Journal of pediatric gastroenterology and nutrition 57 (6), 813-816, 2013 | 32 | 2013 |
| Epidemiological and clinical features of Kawasaki disease during the COVID-19 pandemic in the United States JA Burney, SC Roberts, LL DeHaan, C Shimizu, EV Bainto, ... JAMA network open 5 (6), e2217436-e2217436, 2022 | 31 | 2022 |
| The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: a phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease SC Roberts, S Jain, AH Tremoulet, KK Kim, JC Burns, V Anand, ... Contemporary Clinical Trials 79, 98-103, 2019 | 31 | 2019 |
| Local production of inflammatory mediators during childhood parainfluenza virus infection RE El Feghaly, L McGann, CA Bonville, PJ Branigan, M Suryadevera, ... The Pediatric infectious disease journal 29 (4), e26-e31, 2010 | 31 | 2010 |
| A quality improvement initiative: reducing blood culture contamination in a children’s hospital RE El Feghaly, J Chatterjee, K Dowdy, LM Stempak, S Morgan, ... Pediatrics 142 (4), 2018 | 27 | 2018 |
| The molecular basis of Clostridium difficile disease and host response RE El Feghaly, H Bangar, DB Haslam Current opinion in gastroenterology 31 (1), 24-29, 2015 | 26 | 2015 |
| The inflammasome and type-2 immunity in Clostridium difficile infection A Donlan, WA Petri Jr Clinics in colon and rectal surgery 33 (02), 067-072, 2020 | 16 | 2020 |
| Novel outpatient antibiotic prescribing report of respiratory infections in a pediatric health system's emergency departments and urgent care clinics RE El Feghaly, A Burns, JL Goldman, A Myers, AV Purandare, BR Lee American journal of infection control 49 (3), 398-400, 2021 | 14 | 2021 |
| Proposed metrics to benchmark antibiotic prescribing in pediatric outpatient settings NM Poole, BA Wattles, RE El Feghaly, SOPCB Subgroup American journal of infection control 49 (12), 1547-1550, 2021 | 9 | 2021 |
| Impact of an antibiotic stewardship program on antibiotic choice, dosing, and duration in pediatric urgent cares A Nedved, BR Lee, M Hamner, A Wirtz, A Burns, RE El Feghaly American journal of infection control 51 (5), 520-526, 2023 | 8 | 2023 |
| A newborn with hydrops, hydrocephalus, and ophthalmologic abnormalities RE El Feghaly, DA Hunstad Journal of the Pediatric Infectious Diseases Society 2 (4), 391-393, 2013 | 8 | 2013 |
| Afebrile infants evaluated in the emergency department for serious bacterial infection AS Miller, LE Hall, KM Jones, C Le, RE El Feghaly Pediatric emergency care 33 (8), e15-e20, 2017 | 7 | 2017 |
| Editorial Commentary: Clostridium difficile in Children: Colonization and Consequences RE El Feghaly, PI Tarr Clinical infectious diseases 57 (1), 9-12, 2013 | 7 | 2013 |
| Outpatient antimicrobial stewardship programs in pediatric institutions in 2020: status, needs, barriers RE El Feghaly, EA Monsees, A Burns, A Wirtz, BR Lee, AL Hersh, ... Infection Control & Hospital Epidemiology 43 (10), 1396-1402, 2022 | 6 | 2022 |
| Considerations for implementation: Pediatric outpatient antimicrobial stewardship program EA Monsees, AN Burns, BR Lee, A Wirtz, RE El Feghaly American journal of infection control 49 (12), 1543-1546, 2021 | 6 | 2021 |
